MIM
NUVB icon

Monashee Investment Management’s Nuvation Bio NUVB Stock Holding History

Monashee Investment Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500,000
Closed -$5.22M – 456
2021
Q1 		$5.22M Buy
+500,000
New +$5.59M 0.8% 21
2020
Q4 		– Sell
-79,998
Closed -$896K – 310
2020
Q3 		$896K Buy
+79,998
New +$864K 0.19% 100

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Monashee Investment Management's NUVB Position: Q2 2021 in Review

Monashee Investment Management sold out of Nuvation Bio (NUVB) in Q2 2021, closing a stake of 500,000 shares — an estimated $5.22M sold.

Monashee Investment Management first reported a position in NUVB in Q3 2020 and held it in 2 quarters. The position peaked at $5.22M in Q1 2021. 99 funds tracked by Wall St. Rank hold NUVB as of Q2 2021.

  • Monashee Investment Management reported no remaining Nuvation Bio position as of Q2 2021 after selling out during the quarter.
  • Monashee Investment Management sold 500,000 Nuvation Bio shares in Q2 2021, an estimated $5.22M.
  • Monashee Investment Management first reported a position in Nuvation Bio in Q3 2020 and held it in 2 quarters.
  • Monashee Investment Management's Nuvation Bio position peaked at $5.22M in Q1 2021.
  • 99 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2021.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.